Ensysce Biosciences, Inc. — Director's Dealing 2017

Dec 2, 2017

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Leisure Acquisition Corp. (LACQ)
CIK: 0001716947
Period of Report: 2017-12-01

Reporting Person: WEIL A LORNE (Director, Executive Chairman, 10% Owner)
Reporting Person: Hydra LAC, LLC (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	494711	Direct
Common Stock	1169517	Indirect

Footnotes

F1: Includes an aggregate of 40,645 shares held by Mr. Weil that are subject to forfeiture to the extent that the underwriters' overallotment option in the Company's initial public offering is not exercised. Includes an aggregate of 187,166 shares that are expected to be forfeited upon consummation of the Company's initial public offering pursuant to the securities subscription agreement by and between such reporting person and the Company.

F2: Includes an aggregate of 132,159 shares held by Hydra LAC, LLC, an affiliate of a sponsor of the Company (the "Sponsor Affiliate") that are subject to forfeiture to the extent that the underwriters' overallotment option in the Company's initial public offering is not exercised. Includes an aggregate of 169,517 shares that are expected to be forfeited upon consummation of the Company's initial public offering pursuant to the securities subscription agreement by and between such reporting person and the Company.

F3: Represents shares of common stock held by the Sponsor Affiliate. The shares held by the Sponsor Affiliate are beneficially owned by A. Lorne Weil, who has sole voting and dispositive power over the shares held by the Sponsor Affiliate. Mr. Weil owns all of the membership interests in the Sponsor Affiliate. Mr. Weil disclaims beneficial ownership over any securities owned by the Sponsor Affiliate in which he does not have any pecuniary interest.